Research & achievements研究・業績
Research paper研究論文-英文-
2022年度
-
英文 原著他 (PubMed順)2022年度
-
Ischemic change in gastric mucosa due to gastric wall expansion with air supply: Real-time capture in upper gastrointestinal endoscopy
Digestive Endoscopy / 2022
- Matsuno K ,Sonoda T, Tanaka Y
-
-
英文(PubMed順) 2022年度
-
Characterization of innate immune response to hepatitis B virus genotype F acute infection in tree shrew (Tupaia belangeri) model
Front. Virol / 2022
- Kayesh M-E-H, Hashem M-A, Sanada T, Kitab B, Rashid M-H-O, Akter L, Ezzikouri S, Murakami S, Ogawa S, Tanaka Y, Kohara M and Tsukiyama-Kohara K
-
Mac-2 Binding Protein Glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa
J Glob Health / 2022
- Vincent JP, Ndow G, Ogawa S, Ceesay A, Njie R, Sanneh B, Baldeh I, D’Alessandro U, Mendy M, Thursz M, Chemin I, Tanaka Y, Lemoine M, Shimakawa Y
-
Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy
J Hepatol 77,P.967-977 / 2022
- Yuen M-F, Heo J, Kumada H, Suzuki F, Suzuki Y, Xie Q, Jia J, Karino Y, Hou J, Chayama K, Imamura M, Lao-Tan J-Y, Lim S-G, Tanaka Y, Xie W, Yoon J-H, Duan Z, Kurosaki M, Sung-Park J, Labio M-E, Kumar R, Kweon Y-O, Yim H-J, Tao Y, Cremer J, Elston R, Davies M, Baptiste-Brown S, Han K, Campbell F-M, Paff M, Theodore D.
-
Ischemic change in gastric mucosa due to gastric wall expansion with air supply: Real-time capture in upper gastrointestinal endoscopy
Digestive Endoscopy / 2022
- Matsuno K ,Sonoda T, Tanaka Y
-
Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy
J Hepatol / 2022
- Man Fung Yuen1, Jeong Heo2, Hiromitsu Kumada3, Fumitaka Suzuki3, Yoshiyuki Suzuki4, Qing Xie5, Jidong Jia6, Yoshiyasu Karino7, Jinlin Hou8, Kazuaki Chayama9, Michio Imamura10, Judy Y. Lao-Tan11, SengGee Lim12, Tanaka Y, Wen Xie14, Jung-Hwan Yoon15, Zhongping Duan16, Masayuki Kurosaki17, Sung-Jae Park18, Madalinee Eternity Labio19, Rajneesh Kumar20, Young-Oh Kweon21, Hyung Joon Yim22, Yu Tao23, Jennifer Cremer24, Robert Elston25, Matt Davies26, Sharon Baptiste-Brown27, Kelong Han27, Fiona M. Campbell25, Melanie Paff27, Dickens Theodore24
-
Rapid point-of-care test for hepatitis B core-related antigen to diagnose high viral load in resource-limited settings
Clin Gastroenterol Hepatol / 2022
- Shimakawa Y, Gibril Ndow,3,4 Théo Cerceau,1 Amie Ceesay,3 Atsushi Kaneko,5 Akira Hasegawa,5 Naoki Yamamoto,5 Katsumi Aoyagi,5 Jeanne Perpétue Vincent,1 Takehisa Watanabe,6 Masaya Baba,2 Bakary Sanneh,7 Ignatius Baldeh,7 Ramou Njie,8,9 Umberto D’Alessandro,3 Maimuna Mendy,10 Isabelle Chemin,11 Mark R. Thursz,4 Maud Lemoine,4 and Tanaka Y
-
Clinical usefulness of a novel high-sensitivity hepatitis B core-related antigen assay to determine the initiation of treatment for HBV reactivation
J Gastroenterol / 2022
- Suzuki T,Inoue T,Matsuura K,Kusumoto S,Hagiwara S,Ogawa S,Yagi S,Kaneko A,Fujiwara K,Watanabe T,Aoyagi K,Urata Y,Tamori A,Kataoka H,Tanaka Y
-
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels.
J Hepatol. S0168-8278(22)00020-4. / 2022
- Sonneveld MJ, Chiu SM, Park JY, Brakenhoff SM, Kaewdech A, Seto WK, Tanaka Y, Carey I, Papatheodoridi M, van Bömmel F, Berg T, Zoulim F, Ahn SH, Dalekos GN, Erler NS, Höner Zu Siederdissen C, Wedemeyer H, Cornberg M, Yuen MF, Agarwal K, Boonstra A, Buti M, Piratvisuth T, Papatheodoridis G, Chen CH, Maasoumy B; CREATE study group.
-
Management of hepatitis B virus (HBV) reactivation in patients with resolved HBV infection based on a highly sensitive HB core-related antigen assay.
Hepatol Res / 2022
- Hagiwara S, Kusumoto S, Inoue T, Ogawa S, Narita T, Ito A, Ri M, Komatsu H, Suzuki T, Matsuura K, Yagi S, Kaneko A, Aoyagi K, Iida S, Tanaka Y.
-
Blocking neddylation elicits antiviral effect against hepatitis B virus replication.
Mol Biol Rep 49,P.403-412 / 2022
- Abounouh K, Kayesh MEH, Altawalah H, Kitab B, Murakami S, Ogawa S, Tanaka Y, Dehbi H, Pineau P, Kohara M, Benjelloun S, Tsukiyama-Kohara K, Ezzikouri S.
-
Bile acid dysmetabolism in the gut-microbiota-liver axis under hepatitis C virus infection.
Liver Int. 42,P.124-134 / 2022
- Inoue T, Funatsu Y, Ohnishi M, Isogawa M, Kawashima K, Tanaka M, Moriya K, Kawaratani H, Momoda R, Iio E, Nakagawa H, Suzuki Y, Matsuura K, Fujiwara K, Nakajima A, Yoshiji H, Nakayama J, Tanaka Y.
-
Time-course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis.
Hepatol Res 52,P.235-246 / 2022
- Atsukawa M, Tsubota A, Kondo C, Toyoda H, Nakamuta M, Takaguchi K, Watanabe T, Hiraoka A, Uojima H, Ishikawa T, Iwasa M, Tada T, Nozaki A, Chuma M, Fukunishi S, Asano T, Ogawa C, Abe H, Kato K, Hotta N, Shima T, Matsuura K, Mikami S, Tachi Y, Fujioka S, Okubo H, Shimada N, Tani J, Morishita A, Hidaka I, Moriya A, Tsuji K, Akahane T, Okubo T, Arai T, Kitamura M, Morita K, Kawata K, Tanaka Y, Kumada T, Iwakiri K; KTK49 Liver Study Group.
-
Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019.
Sci Rep. 12,P.1517 / 2022
- Nakano M, Yatsuhashi H, Bekki S, Takami Y, Tanaka Y, Yoshimaru Y, Honda K, Komorizono Y, Harada M, Shibata M, Sakisaka S, Shakado S, Nagata K, Yoshizumi T, Itoh S, Sohda T, Oeda S, Nakao K, Sasaki R, Yamashita T, Ido A, Mawatari S, Nakamuta M, Aratake Y, Matsumoto S, Maeshiro T, Goto T, Torimura T.
-
Mac-2-Binding Protein Glycan Isomer Predicts All Malignancies Post-sustained Virological Response in Chronic Hepatitis C
Hepatol Commun / 2022
- Kawata K, Atsukawa M, Ohta K, Chida T, Noritake H, Arai T, Iwakiri K, Yasuda S, Toyoda H, Okubo T, Hiraoka A, Watanabe T, Uojima H, Nozaki A, Tani J, Morishita A, Kageyama F, Sasada Y, Nagasawa M, Matsushita M, Oyaizu T, Mikami S, Ikegami T, Abe H, Matsuura K, Tanaka Y, Tsubota A
-
Endoscopic direct clipping versus indirect clipping for colonic diverticular bleeding: A large multicenter cohort study
United European Gastroenterol J 10,P.93-103 / 2022
- Kishino T, Nagata N, Kobayashi K, Yamauchi A, Yamada A, Omori J, Ikeya T, Aoyama T, Tominaga N, Sato Y, Ishii N, Sawada T, Murata M, Takao A, Mizukami K, Kinjo K, Fujimori S, Uotani T, Fujita M, Sato H, Suzuki S, Narasaka T, Hayasaka J, Funabiki T, Kinjo Y, Mizuki A, Kiyotoki S, Mikami T, Gushima R, Fujii H, Fuyuno Y, Gunji N, Toya Y, Narimatsu K, Manabe N, Nagaike K, Kinjo T, Sumida Y, Funakoshi S, Kawagishi K, Matsuhashi T, Komaki Y, Miki K, Watanabe K, Kaise M.
-
Optimal management of lenvatinib therapy for patients with unresectable hepatocellular carcinoma by balancing the therapeutic effect with the relative dose intensity
Hepatol Res 52,P.105-119 / 2022
- Tokunaga T, Tateyama M, Tanaka K, Narahara S, Inada H, Kurano S, Hayashi S, Yoshimaru Y, Nagaoka K , Watanabe T,Setoyama H, Tanaka M, Tanaka Y.
-
Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine.
Clin Gastroenterol Hepatol 20,P.874-885.e4 / 2022
- Park J, Le AK, Tseng TC, Yeh ML, Jun DW, Trinh H, Wong G LH, Chen CH, Peng CY, Kim SE, Oh H, Kwak MS, Cheung KS, Toyoda H, Hsu YC, Jeong JY, Yoon EL, Ungtrakul T, Zhang J, Xie Q, Ahn SB, Enomoto M, Shim JJ, Cunningham C, Jeong SW, Cho YK, Ogawa E, Huang R, Lee DH, Takahashi H, Tsai PC, Huang CF, Dai CY, Tseng, Yasuda S, Kozuka R, Li J, Wong C, Wong CC, Zhao C, Hoang J, Eguchi Y, Wu C, Tanaka Y, Gane E, Tanwandee T, Cheung R, Yuen MF, Lee HS, Yu ML, Kao JH, Yang HI, Nguyen MH.
-
Identification of microRNA‐96‐5p as a postoperative, prognostic microRNA predictor in nonviral hepatocellular carcinoma.
Hepatol Res 52,P.93-104 / 2022
- Matsui T, Hamada-Tsutsumi S, Naito Y, Nojima M, Iio E, Tamori A, Kubo S, Ide T, Kondo Y, Eguchi Y, Komori A, Morine Y, Shimada M, Utsunomiya T, Shirabe K, Kimura K, Hiasa Y, Chuaypen N, Tangkijvanich P, Ito-Naiki A, Takahashi S, Ochiya T, Tanaka Y.
-